c dif and vanco Flashcards

1
Q

c diff is a ____ disease

A

toxin-mediated intestinal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

classification of c diff bacteria

A

gram (+) anaerobic, spore-forming bacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

c diff transmission

A

most common is fecal-oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

c diff is the primary pathogen responsible for _____

A

antibiotic-associated colitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

why is c diff the most common cause of infectious diarrhea in the healthcare setting

A

disruption of gut flora due to antibiotics, passing spores to others (exposed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the scary c diff strain called

A

NAP1/B1/027

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does strain NAP1/B1/027 cause

A

more severe and more effective transmission, refractory, toxic megacolon, leukemoid reactions (inc WBC), hypoalbuminemia, colectomy, shock, death, complications in elderly due to loss of fluids and electrolytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

symptoms of c diff

A

profuse, watery, malodorous diarrhea multiple times per day interfering with normal activities, abdominal pain, fever, leukocytosis, hypoalbuminemia, abdominal cramps/pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

c diff endoscopy findings

A

widely disseminated, punctuate, yellow plaques, ranging from pinhead sized to confluent pseudomembranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

c diff risk factors

A

exposure to antibiotics (all, but especially clindamycin, cephalosporins, and fluoroquinolones), previous infxn/known exposure, age 65+, weakened immune system, recent hospitalizations, PPIs or H2 blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

avoid ____ with c diff

A

antiperistaltics, including narcotics and loperamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

treatment for first episode c diff

A

pref: fidaxomicin 200 mg po bid x 10d. alt: vancomycin 125 mg po qid x 10d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

alternative for first episode c diff if you can’t give fdx or van

A

metronidazole 500 mg tid x 10-14d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

treatment for first recurrence c diff

A

pref: fidaxomicin 200 mg bid x 10d OR bid x 5d followed by qod x 20d. alt: vanco in a tapered or pulsed regimen OR vanco 125 mg qid x 10d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is an adjunctive treatment for recurrence of CDI during standard of care

A

bezlotoxumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what class is fidaxomicin

A

macrolide

17
Q

what is the mechanism of fidaxomicin

A

inhibits protein synthesis via RNA polymerase

18
Q

fidaxomicin pk

A

minimal systemic absorption/nonabsorbed: stays in GI tract

19
Q

fidaxomicin ade

A

n/v, abdominal pain. rare: GI hemorrhage, bowel obstruction, anemia, neutropenia

20
Q

treatment for second or subsequent CDI recurrence

A

FDX 200 mg BID x 10 or BID x 5 then qod x 20. Vanco tapered and pulsed, or 125 qid x 10 then rifaximin 400 mg tid x 20. fecal microbiota transplant. adjuncts to SOC abx: bezlotoxumab

21
Q

when is FMT indicated

A

3 CDI episodes

22
Q

definition of fulminant CDI

A

hypotension or shock, ileus, megacolon

23
Q

treatment for fulminant CDI

A

vancomycin 500 mg po qid, rectal vancomycin, IV metronidazole 500 mg q8h

24
Q

stop FMT recipient’s anti-c diff antibiotics at least __ days before

A

5

25
Q

bezlotoxumab indication

A

reduce the recurrence of c diff in patients 18+. NOT for treatment or for monotherapy. must be used with standard of care antibiotics

26
Q

bezlotoxumab dose

A

single dose: 10 mg/kg IV given over 1 hour

27
Q

bezlotoxumab precaution

A

heart failure

28
Q

vancomycin structure

A

cyclic glycopeptide

29
Q

vancomycin MOA

A

binds to D-ala D-ala via hydrogen bonds, covers the substrate for cell wall transamidase (transpeptidase) preventing the cross linkage and causing osmotically defective cell walls

30
Q

vancomycin spectrum

A

gram + only: MRSA, MSSA, staph, strep, enterococcal, c diff. no gram - activity

31
Q

vancomycin absorption

A

not absorbed systemically when given PO. oral vanco is for c diff. IV vanco is for systemic infections

32
Q

vanco elimination

A

renal: dose adjustments are necessary

33
Q

what is the risk with vancomycin

A

nephrotoxicity: mitigated by exposure AUC: MIC 400-600

34
Q

vancomycin infusion reaction (“redman’s syndrome)

A

a histamine-induced reaction when IV administration is too rapid causing hypotension, flushing, erythematous rash

35
Q

treatment for vancomycin infusion reaction

A

po antihistamines or iv corticosteroids

36
Q

other ade for vancomycin

A

eosinophilia, thrombocytopenia, neutropenia, ototoxicity from 8th cranial nerve damage